Stocks›Healthcare
WatchAlert

Nephrocare Health Services Limited

NEPHROPLUS · NSE · Healthcare · As of 8 Nov 2026
₹619.45
+₹17.70 (+2.94%)(1D)
₹446.00Since listing range₹781.50
Market Cap
₹6,220 Cr
P/E (Sector)
47.7 (32.3)
P/B Ratio
5.57
Dividend Yield
—
ROE
11.7%
Debt / Equity
0.07
Anvest Score
54/100
  • Valuation
    63
  • Quality
    41
  • Growth
    26
  • Health
    94
  • Momentum
    52

Fundamentals

P/E Ratio (TTM)
47.69
Sector median P/E
32.29
P/B Ratio
5.57
Sector median P/B
4.4
EPS (TTM)
₹12.99
Market Cap
₹6,220 Cr
ROE
11.68%
ROCE
13.44%
Profit Margin
7.51%
Debt/Equity
0.07
Current Ratio
2.8
Interest Coverage
2.67
Book Value
₹111.18
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

Nephrocare Health Services Limited FAQs

3 topics
Expand
What does the Nephrocare Health Services Limited (NEPHROPLUS) stock page cover?
Nephrocare Health Services Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for NEPHROPLUS?
Nephrocare Health Services Limited is currently shown with a delayed price near ₹619.45, P/E 47.69, and ROE 11.68%.
Does the NEPHROPLUS page provide investment advice?
No. The NEPHROPLUS page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights